Check-Cap Ltd.
Check-Cap Ltd. (CHEK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CHEK · as of Jun 8, 2026
Key Statistics
Explore Check-Cap Ltd. Data
chek stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 66.7%
Competitors & Peers
chek competitorsCHEK
ACXP
ADIL
BFRI
GBS
HCWBStock Performance
Full HistoryAbout Check-Cap Ltd.
Check-Cap Ltd. is an Israeli medical diagnostics company currently in the clinical development phase. It is dedicated to advancing a novel capsule-based screening method that employs ultra-low-dose X-…
what is check-cap ltd. · chek stock overview · check-cap ltd. company profile · who is check-cap ltd. ceo · chek NASDAQ · check-cap ltd. headquarters · check-cap ltd. business segments
About Stock Overview & Key Data
Check-Cap Ltd. (CHEK) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Mar 4, 2015. As of the latest trading session, CHEK stock price is $1.86, with a market capitalization of $10.9M. The stock has returned +132.33% over the past 12 months and +10.06% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Check-Cap Ltd. stock is Buy, with an average 12-month price target of $—. In fiscal year 2024, Check-Cap Ltd. reported revenue of — and net income of -$25.1M. For detailed data — including Check-Cap Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Check-Cap Ltd. (CHEK) stock price is $1.86. The stock is traded on NASDAQ under the ticker symbol CHEK. The 52-week range is $0.56 – $3.13.